KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash & Current Investments (2017 - 2025)

Guardant Health's Cash & Current Investments history spans 9 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 43.05% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 43.05%, while the annual FY2025 figure was $1.2 billion, 43.05% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $1.2 billion at Guardant Health, up from $580.0 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $1.9 billion in Q1 2021 and bottomed at $580.0 million in Q3 2025.
  • The 5-year median for Cash & Current Investments is $960.2 million (2022), against an average of $1.1 billion.
  • The largest annual shift saw Cash & Current Investments skyrocketed 273.1% in 2021 before it tumbled 52.35% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $932.7 million in 2021, then increased by 8.41% to $1.0 billion in 2022, then grew by 15.57% to $1.2 billion in 2023, then decreased by 28.12% to $840.0 million in 2024, then surged by 43.05% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for GH's Cash & Current Investments are $1.2 billion (Q4 2025), $580.0 million (Q3 2025), and $629.1 million (Q2 2025).